Schonfeld Strategic Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $435K | Buy |
53,771
+40,871
| +317% | +$331K | ﹤0.01% | 1504 |
|
|
2025
Q1 | $108K | Buy |
+12,900
| New | +$108K | ﹤0.01% | 1884 |
|
|
2023
Q3 | – | Sell |
-23,700
| Closed | -$73.5K | – | 1604 |
|
|
2023
Q2 | $73.5K | Sell |
23,700
-300
| -1% | -$930 | ﹤0.01% | 1671 |
|
|
2023
Q1 | $33.4K | Sell |
24,000
-4,900
| -17% | -$6.81K | ﹤0.01% | 1743 |
|
|
2022
Q4 | $57.5K | Sell |
28,900
-3,452
| -11% | -$6.87K | ﹤0.01% | 2211 |
|
|
2022
Q3 | $65K | Buy |
+32,352
| New | +$65K | ﹤0.01% | 2549 |
|
|
2021
Q2 | – | Sell |
-61,567
| Closed | -$414K | – | 1870 |
|
|
2021
Q1 | $414K | Buy |
61,567
+27,067
| +78% | +$182K | 0.01% | 1170 |
|
|
2020
Q4 | $157K | Buy |
+34,500
| New | +$157K | ﹤0.01% | 1348 |
|
|
2018
Q4 | – | Sell |
-188,700
| Closed | -$4.19M | – | 1043 |
|
|
2018
Q3 | $4.19M | Buy |
188,700
+125,828
| +200% | +$2.79M | 0.19% | 155 |
|
|
2018
Q2 | $1.03M | Buy |
+62,872
| New | +$1.03M | 0.06% | 386 |
|